Cargando…

Effect of hydroxychloroquine in patients with IgA nephropathy with insufficient responses to immunosuppressive therapy: a retrospective case-control study

BACKGROUND: Hydroxychloroquine (HCQ) is a well-known immunomodulator that was recently used in immunoglobulin A (IgA) nephropathy (IgAN) due to its antiproteinuric effects. We investigated the effects of HCQ in patients with IgAN whose proteinuria remained above 1 g/d after conventional immunosuppre...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tang, Chen, Lv, Ji-Cheng, Shi, Su-Fang, Chen, Yu-Qing, Liu, Li-Jun, Zhang, Hong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7653892/ https://www.ncbi.nlm.nih.gov/pubmed/33172397 http://dx.doi.org/10.1186/s12882-020-02141-9

Ejemplares similares

Comparison of the effects of hydroxychloroquine and corticosteroid treatment on proteinuria in IgA nephropathy: a case-control study
por: Yang, Ya-zi, et al.
Publicado: (2019)

Comparison between hydroxychloroquine and systemic corticosteroids in IgA nephropathy: a two-year follow-up study
por: Si, Feng-Lei, et al.
Publicado: (2023)

Characteristics of patients with coexisting IgA nephropathy and membranous nephropathy
por: Chen, Pei, et al.
Publicado: (2018)

Hydroxychloroquine in IgA nephropathy: a systematic review
por: Stefan, Gabriel, et al.
Publicado: (2021)

Increased APRIL Expression Induces IgA1 Aberrant Glycosylation in IgA Nephropathy
por: Zhai, Ya-Ling, et al.
Publicado: (2016)

Hydroxychloroquine Reduces Proteinuria in Indian Patients With IgA Nephropathy
por: Bagchi, Soumita, et al.
Publicado: (2022)

Pathogenic role of glycan-specific IgG antibodies in IgA nephropathy
por: Zhao, Yan-feng, et al.
Publicado: (2017)

Clinical features of IgA nephropathy with serum ANCA positivity: a retrospective case–control study
por: Yang, Ya-zi, et al.
Publicado: (2015)

Concurrent IgA Nephropathy and Membranous Nephropathy, Is It an Overlap Syndrome?
por: He, Jia-Wei, et al.
Publicado: (2022)

The predictive value and response to immunosuppressive therapy of IgA nephropathy patients with crescents in a large retrospective Chinese cohort
por: Guo, Yingman, et al.
Publicado: (2023)

Secondary IgA Nephropathy Shares the Same Immune Features With Primary IgA Nephropathy
por: Wang, Manliu, et al.
Publicado: (2019)

Corrigendum: Concurrent IgA nephropathy and membranous nephropathy, is it an overlap syndrome?
por: He, Jia-Wei, et al.
Publicado: (2023)

Serum Soluble CD89-IgA Complexes Are Elevated in IgA Nephropathy without Immunosuppressant History
por: Wu, Haiting, et al.
Publicado: (2020)

Visit-to-visit variability in blood pressure and kidney disease progression in IgA nephropathy
por: Tang, Chen, et al.
Publicado: (2022)

Role of immunosuppressive therapy and predictors of therapeutic effectiveness and renal outcome in IgA nephropathy with proteinuria
por: Ruan, Yiping, et al.
Publicado: (2015)

Identification and external validation of IgA nephropathy patients benefiting from immunosuppression therapy
por: Chen, Tingyu, et al.
Publicado: (2020)

Homocysteine and IgA nephropathy: observational and Mendelian randomization analyses
por: Zhang, Yue-Miao, et al.
Publicado: (2020)

Effect of Immunosuppressive Drugs on the Changes of Serum Galactose-Deficient IgA1 in Patients with IgA Nephropathy
por: Kim, Min Jeong, et al.
Publicado: (2016)

Efficacy and safety of sequential immunosuppressive treatment for severe IgA nephropathy: A retrospective study
por: Luo, Mian-Na, et al.
Publicado: (2023)

Effects of Hydroxychloroquine on Proteinuria in IgA Nephropathy: A Systematic Review and Meta-Analysis
por: Zhang, Jialing, et al.
Publicado: (2021)

The efficacy and safety of immunosuppressive therapies in the treatment of IgA nephropathy: A network meta-analysis
por: Tan, Jiaxing, et al.
Publicado: (2020)

T lymphocytes in IgA nephropathy
por: Tang, Yuyan, et al.
Publicado: (2020)

Corticosteroids or immunosuppressants were not superior to supportive care in IgA nephropathy patients with mild proteinuria
por: Pei, Gaiqin, et al.
Publicado: (2020)

Has The Time Arrived to Refine The Indications of Immunosuppressive Therapy and Prognosis in IgA Nephropathy?
por: Obrișcă, Bogdan, et al.
Publicado: (2019)

The Role of IgA in the Pathogenesis of IgA Nephropathy
por: Perše, Martina, et al.
Publicado: (2019)

Cumulative Effects of Variants Identified by Genome-wide Association Studies in IgA Nephropathy
por: Zhou, Xu-Jie, et al.
Publicado: (2014)

Machine learning in predicting T-score in the Oxford classification system of IgA nephropathy
por: Xu, Lin-Lin, et al.
Publicado: (2023)

Zonulin, as a marker of intestinal permeability, is elevated in IgA nephropathy and IgA vasculitis with nephritis
por: Li, Qianqian, et al.
Publicado: (2022)

Immunosuppressive Treatment in Children With IgA Nephropathy and the Clinical Value of Podocytopathic Features
por: Cambier, Alexandra, et al.
Publicado: (2018)

The prognostic effect of immunosuppressive therapy in IgA nephropathy with stage 3 or 4 chronic kidney disease
por: Yang, Xiaoxia, et al.
Publicado: (2021)

Elevated Soluble VEGF Receptor sFlt-1 Correlates with Endothelial Injury in IgA Nephropathy
por: Zhai, Ya-Ling, et al.
Publicado: (2014)

Immunosuppressive agents versus steroids in the treatment of IgA nephropathy-induced proteinuria: A meta-analysis
por: Liu, Yanli, et al.
Publicado: (2016)

Immunosuppressive agents versus steroids in the treatment of IgA nephropathy-induced proteinuria: A meta-analysis
por: Liu, Yanli, et al.
Publicado: (2019)

The Role of Complement in Microangiopathic Lesions of IgA Nephropathy
por: Li, Jingyi, et al.
Publicado: (2022)

IgA Vasculitis and IgA Nephropathy: Same Disease?
por: Pillebout, Evangeline
Publicado: (2021)

Efficacy and Safety of Immunosuppressive Monotherapy Agents for IgA Nephropathy: A Network Meta-Analysis
por: Han, Shisheng, et al.
Publicado: (2021)

Comparative study on clinicopathological features and prognosis of IgA vasculitis nephritis and IgA nephropathy in children
por: Lv, Yan, et al.
Publicado: (2023)

Current treatment of IgA nephropathy
por: Floege, Jürgen, et al.
Publicado: (2021)

Tripterygium Wilfordii inhibits tonsillar IgA production by downregulating IgA class switching in IgA nephropathy
por: Li, Huining, et al.
Publicado: (2017)

Novel identified associations of RGS1 and RASGRP1 variants in IgA Nephropathy
por: Zhou, Xu-Jie, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_h67i8mvjgae4teor7ecsas88o6